KARA KIM: Open Payments
NPI 1033702535 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 25 payments from 12 companies in 2025. Trend: 2023 $280 · 2024 $334 · 2025 $700
Food & beverage: $658Education: $43
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $203 |
| Galderma Laboratories, L.P. | 6 | $177 |
| ABBVIE INC. | 5 | $91 |
| Incyte Corporation | 2 | $54 |
| UCB, Inc. | 1 | $26 |
| LEO Pharma Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| GENZYME CORPORATION | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Organon LLC | 1 | $20 |
Products named: TREMFYA, NEMLUVIO, SKYRIZI, OPZELURA, Bimzelx, ANZUPGO, COSENTYX, DUPIXENT.
Industry payments across TX — which companies pay providers there.
